Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
Phase III
· Site: SITE011 (ITA) (Dr. Jansen)
· consented 2023-03-02
Adverse events
6
Serious AEs
1
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2023-05-11 (study day 58); relationship: not assessed
severe
serious
assessed
2026-08-18
Grade 4 Asthenia — outcome: RECOVERED/RESOLVED; onset 2023-06-13 (study day 91); relationship: not assessed; serious criteria: life-threatening
moderate
assessed
2026-08-18
Grade 2 Fatigue — outcome: RECOVERED/RESOLVED; onset 2023-06-22 (study day 100); relationship: not assessed
mild
assessed
2026-08-18
Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-11-08 (study day 239); relationship: N
moderate
assessed
2026-08-18
Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-12-13 (study day 274); relationship: not assessed
severe
assessed
2026-08-18
Grade 3 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2023-12-27 (study day 288); relationship: N
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.